NCT03055013 2026-04-13Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing NephrectomyNational Cancer Institute (NCI)Phase 3 Active not recruiting819 enrolled 12 charts
NCT07516366 2026-04-13Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT TrialNational Cancer Institute (NCI)Phase 2 Not yet recruiting16 enrolled